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Edited by Sandro SonninoAbstract Glycolipids of Mycobacterium leprae obtained from
armadillo tissue nodules infected with the bacteria were ana-
lyzed. Mass spectrometric analysis of the glycolipids indicated
the presence of trehalose 6,6 0-dimycolate (TDM) together with
trehalose 6-monomycolate (TMM) and phenolic glycolipid-I
(PGL-I). The analysis showed that M. leprae-derived TDM
and TMM possessed both a- and keto-mycolates centering at
C78 in the former and at C81 or 83 in the latter subclasses,
respectively. For the ﬁrst time, MALDI-TOF mass analyses
showed the presence of TDM in M. leprae.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Mycobacterium leprae1. Introduction
Mycolic acids and mycolyl glycolipids are unique and ubiqui-
tous components of mycobacterial cell envelopes. Among such
components, trehalose 6,6 0-dimycolate (TDM) was ﬁrst iso-
lated as cord factor from highly virulentMycobacterium tuber-
culosis showing cord-like growth on the surface culture in liquid
media [1–3]. TDM of M. tuberculosis was recognized as one of
the virulence factors capable of inhibiting fusion of phagosome
with lysosome in infected macrophage [4]. However, on the
other hand, the TDMwas considered to be associated with host
defence against the mycobacterial infection since it induced im-
mune responses such as type 1 T cell activation and the forma-
tion of granuloma in the mycobacteria-infected lesion [5–7].
Wang et al. have reported that a high proportion of patients in-
fected withMycobacterium leprae possess IgG antibody against
TDM of unknown origin as well as trehalose 6-monomycolate
(TMM), a biosynthetic precursor of TDM [8]. These observa-Abbreviations: TDM, trehalose 6,6 0-dimycolate; TMM, trehalose 6-
monomycolate; M. leprae, Mycobacterium leprae; M. tuberculosis,
Mycobacterium tuberculosis; M. bovis, Mycobacterium bovis; TLC,
thin-layer chromatography; MALDI-TOF mass, matrix-assisted laser
desorption/ionization time-of-ﬂight mass spectrometry
*Corresponding author. Fax: +81 42 391 8807.
E-mail address: mkai@nih.go.jp (M. Kai).
0014-5793/$32.00  2007 Federation of European Biochemical Societies. Pu
doi:10.1016/j.febslet.2007.06.029tions suggest the possible existence of both TDM and TMM
in M. leprae. Previously, TDM has been isolated from almost
all species of culturable mycobacteria [9,10], and also TMM
was isolated from M. leprae, however, the search for TDM in
M. leprae has been unsuccessful [11]. The possible reason for
not being able to identify TDM, may be due to (1) inadequate
supply of M. leprae, (2) negligible amount of the product, (3)
technically ineﬃcient to identify TDM. Recent development
of newer techniques such as MALDI-TOF mass spectrometry
has enabled us to identify even several pg amounts of products.
Therefore, the present study was designed as an attempt to
directly detect TDM in M. leprae, by use of newer technolo-
gies. In the process, higher amounts of M. leprae phenolic
glycolipid-I (PGL-I) was obtained which was analyzed by
MALDI-TOF mass spectrometry.2. Materials and methods
2.1. Sources for extraction of glycolipids
M. tuberculosis Aoyama B (ATCC 31726) and Mycobacterium bovis
BCG Connaught (ATCC 35745) were grown at 37 C on Sauton’s
medium for four weeks as surface pellicles until early stationary phase.
Cultivated mycobacterial strains were used for extraction of glycolip-
ids. Because M. leprae cannot be cultivated in any artiﬁcial media,
armadillo tissue nodules infected with M. leprae (Thai 53 strain) were
used for the extraction of glycolipids.
2.2. Extraction of glycolipids and mycolic acid methyl esters
Glycolipids were extracted according to the methods described pre-
viously [12]. In brief, bacterial culture or tissues infected withM. leprae
[13] were autoclaved at 121 C for 15 min and collected by centrifuga-
tion. Lipids were extracted from homogenized tissue with 20 volumes
of chloroform/methanol (2:1, v/v) three times with vigorous grinding.
The two phases were separated in a funnel, the lower organic phase
was collected, and the solvent was evaporated from the organic phase.
The total lipids were separated by solvent fractionation and tetrahy-
drofuran-soluble fraction was further separated by thin-layer chroma-
tography (TLC) on silica gel plates (Uniplate; Analtech Inc. Newark,
DE) with the solvent system of chloroform/methanol/water (90:10:1,
by vol.) or chloroform/methanol/acetone/acetic acid (90:10:6:1, by
vol.). Glycolipid spots were visualized with a 9 M H2SO4 spray fol-
lowed by charring at 200 C for 10 min or with iodine vapor for pre-
parative purposes.
To determine the subclass composition of the mycolic acids in each
mycobacterial TMM and TDM, mycolic acid methyl esters were pre-
pared by alkaline hydrolysis of glycolipids. The glycolipids were hydro-
lyzed with 1.25 M NaOH in 90% methanol at 70 C for 1 h and the
resultant mycolic acids were then extracted with n-hexane after acidiﬁ-
cation with HCl, followed by methylation with benzene/methanol/
H2SO4 (10:20:1, by vol.) [14]. Mycolic acid methyl esters from eachblished by Elsevier B.V. All rights reserved.
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Fig. 1. Thin-layer chromatograms (TLC) of solvent extracts from
tetrahydrofuran soluble fraction and mycolic acid methyl ester
subclasses of M. tuberculosis, M. bovis BCG Connaught, and M.
leprae. (A) TLC of mycolic acid methyl ester subclasses with the
solvent system of benzene/methanol/H2SO4 (10:20:1, by vol.). Mycolic
acid methyl ester subclasses of M. tuberculosis (TB); a-, methoxy- and
3346 M. Kai et al. / FEBS Letters 581 (2007) 3345–3350glycolipid were fully separated into subclasses by TLC with the solvent
system of benzene in a draft chamber under reduced pressure.
2.3. Mass spectrometry analysis
Analysis by matrix-assisted laser desorption/ionization time-of-ﬂight
mass spectrometry (MALDI-TOF mass) was carried out on a Voyager
DE-STR (Applied Biosystems, Tokyo, Japan) with pulsed UV light
(337 nm) from an N2 laser, essentially according to the method re-
ported previously [14]. TDM and TMMwere analyzed in the reﬂectron
mode by the instrument operated at 20 kV in the positive ion mode.
The 2,5-dihydroxybenzoic acid (2,5-DHB) matrix was used at a con-
centration of 10 mg/ml in chloroform/methanol (2:1 v/v). Typically,
5 ll of TDM or TMM samples (5 lg) in chloroform/methanol (2:1 v/
v) solution and 5 ll of the matrix solution were mixed, and 1.5 ll of
the mixture was applied on a sample plate. An external mass spectrum
calibration was performed using calibration mixture 2 of the Sequa-
zyme Peptide Mass Standards kit (Applied Biosystems), including
known peptide standards in a mass range from 1290 to 5700 Da.
The molecular mass of mycobacterial TMM, TDM, and PGL-I was
determined based on the quasimolecular mass ions [M+Na]+ by the
reﬂectron mode. In general, nominal number of atomic mass is used
for calculation of number of molecular mass. However, there is a slight
diﬀerence between nominal mass number and accurate mass number
read from spectrometry [15]. For instance, when both of the two mol-
ecules of mycocerosates (R1and R2) in PGL-I are C32, the nominal
mass number [M+Na]+ of PGL-I (C124H232O19) is [(C · 124) +
(H · 232) + (O · 19) + (Na · 1)] = 2047 (2024 + 23), but the accurate
number is 2050.15 [(12.0107 · 124) + (1.00794 · 232) + (15.9994 ·
19) + 22.9898]. The nominal mass numbers are given in the text.keto-mycolic acid methyl esters are shown with the mycolic acid
methyl ester mixture of glycolipids derived from armadillo tissue
nodules infected with M. leprae (ML), and those of M. bovis BCG
Connaught (BCG-C). (B) TLC of solvent extracts from M. leprae
(ML) and M. tuberculosis (TB) with the solvent system of chloroform/
methanol/acetone/acetic acid (90:10:6:1, by vol.). Trehalose mono-
mycolate (TMM) and trehalose di-mycolate (TDM) bands of TB were
identiﬁed previously and used as references in this TLC. Fractions 1–4
separated from the ﬁnal extracts of M. leprae and designated M1–4.3. Results
3.1. TLC analysis of mycolic acids methyl ester
To determine the subclass composition of the mycolic acids
in each mycobacterial TMM and/or TDM, mycolic acid
methyl esters were analyzed by TLC. The TLC analysis indi-
cated that fatty acid methyl esters had two spots corresponding
to either a- and keto-mycolic acid (Fig. 1A). The same two
spots pattern was observed for M. bovis BCG Connaught
(BCG-C) and M. leprae while three spots were detected for
M. tuberculosis corresponding to a-, methoxy-, and keto-
mycolic acid [16,17]. The bottom spot in ML lane could be
cholesterol from armadillo’s tissues (data not shown).
3.2. MALDI-TOF-MS analysis of TMM
We separated the ﬁnal solvent extracts ofM. leprae into four
fractions (M1–M4). Fig. 1B shows a thin-layer chromatogram
of the TMM and TDM from M. tuberculosis and the solvent
fractionated glycolipids from M. leprae. M. leprae exhibited
bands, which were faint, but signiﬁcantly reddish glycolipid-
like, migrating close to bands of TDM or TMM of M. tuber-
culosis. The major bands of M2 and M4 migrated close to
TDM and TMM positions of M. tuberculosis, respectively.
Therefore, we tried to carefully analyze the bands which may
correspond to TDM and TMM by mass spectrometry.
Major band in M4 in Fig. 1B was analyzed using BCG-C as
a reference. The mass spectra of TMM from BCG-C showed a
biphasic distribution of pseudomolecular ions, [M+Na]+
(Fig. 2A). In the higher mass ranges of BCG-C TMM, domi-
nant ions were detected at m/z 1555, 1583, 1597, 1611 and
1625 due to [M+Na]+ of C82, C84, C85, C86 and C87 keto
mycolyl TMM, and the major mass ions in the lower mass
ranges were detected at m/z 1455, 1483, 1511 and 1539 due
to [M+Na]+ of a-mycolyl TMM centering at C78, respectively
(Fig. 2A) [18]. On the other hand, M. leprae derived TMM
showed in lower mass ranges at m/z 1427, 1455, 1483, 1511and 1539 due to [M+Na]+ of a-mycolyl TMM centering at
C78 same to that of BCG-C (Fig. 2B). In the higher mass
ranges, dominant ions were shifted lower and the major ions
were detected at m/z 1541, 1569 and 1597 (Fig. 2B), indicating
the major keto-mycolyl TMM consisted of C81, C83 or C85
mycolate, respectively. The molecular species of TMM from
M. leprae and that from BCG-C are summarized in Table 1.
These results indicate that M. leprae possess trehalose 6-mon-
omycolate, with C78 a- and C83 keto-mycolates, as the major
molecular species.
3.3. MALDI-TOF-MS analysis of TDM
TDM from BCG-C showed a diverse distribution of mass
ions according to the combination of di a-, a- and keto-, and
di keto-mycolic acid subclasses and each molecular species,
that leads to a multiphasic distribution of mass ions due to
the dominant combination of a–a, a–keto and keto–keto dim-
ycolyl TDM (Fig. 2C). Given the small sample size, the identi-
ﬁcation ofM. leprae TDM was achieved primarily on the thin-
layer chromatographic behavior and MALDI-TOF mass anal-
ysis, in comparison with the analytical results from BCG-C
possessing the same mycolic acid subclasses. Fig. 2D shows
the positive MALDI-TOF mass spectra of M. leprae TDM
(Fig. 1B, M2). In contrast to TDM from BCG-C, TDM from
M. leprae showed a distinctive mass ion distribution shifted to
lower mass ranges due to the major combinations of a–a dim-
ycolyl TDM and a–keto dimycolyl TDM with a small shoulder
due to keto–keto dimycolyl TDM. In M. leprae TDM, major
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Fig. 2. MALDI-TOF-MS spectra of TMM and TDM. (A) TMM of M. bovis BCG Connaught, (B) TMM of M. leprae Thai 53, (C) TDM of M.
bovis BCG Connaught, (D) TDM of M. leprae Thai 53.
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Table 1
MALDI-TOF mass spectrometry data of the individual types of TMM from M. leprae (Thai 53) and M. bovis BCG (Connaught)
Species
(strain)
Mycolic
acid
typea
Total carbon number of TMM mycolate
74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91
M. leprae
(Thai 53)
I 1427 1455 1483 1497 1511 1525 1539 1553
II 1471 1499 1527 1541 1555 1569 1583 1597
M. bovis BCG
(Connaught)
I 1455 1469 1483 1511 1539
II 1555 1569 1583 1597 1611 1625 1639 1653 1667 1681
aI; a-dicyclopropanoic or dienoic, II; keto-monocyclopropanoic or monoenoic. Major homologues are shown in bold.
3348 M. Kai et al. / FEBS Letters 581 (2007) 3345–3350mass ions due to molecular species possessing C76, C78, C80
a–a dimycolic acids were detected at m/z 2573, 2601 and
2629, and those possessing a–keto dimycolic acids at m/z
2659, 2687 and 2715, and those possessing keto–keto dimycolic
acids at m/z 2731, 2745, 2773 and 2801, respectively. The de-
duced molecular species of TDM fromM. leprae and that from
BCG-C are summarized in Table 2.
3.4. MALDI-TOF-MS analysis of PGL-I
The MALDI-TOF mass spectra of M2 in Fig. 1B showed
the existence of TDM as described above, however, the major
cluster ions in mass spectra of M2 were observed in lower mass
ranges from around m/z 1990 to 2100. So, we analyzed the
spectra in more detail. The result indicates that the cluster ions
are derived from phenolic glycolipid-I (PGL-I) (Fig. 3A). The
nominal mass number of the PGL-I, which is assumed to have
two molecules of C32 mycocerosates, was m/z 2047 (Fig. 3A
and B). Thus, the deduced combination of mycocerosic acids
with diﬀerent carbon numbers in PGL-I are shown in
Fig. 3A and the general structure of PGL-I is shown in
Fig. 3B.Table 2
Most probable combination of mycolic acids constructing TDM from M. le
Mass no. of TDM (m/z) M. leprae (Thai 53)
2573 a76:a78
2601 a76:a80, a78:a78
2617 a74:k82, a76:k80, a78:k78, a
2629 a78:a80
2645 a74:k84, a76:k82, a78:k80, a
2659 a76:k83, a78:k81
2673 a76:k84, a78:k82, a79:k81, a
2687 a78:k83, a80:k81
2701 a78:k84, a79:k83, a80:k82, a
2715 a80:k83
2729
2731 k80:k83, k81:k82
2743
2745 k81:k83
2757
2773 k83:k83
2787
2801 k83:k85, k84:k84
2815
2829
2843
2857
2871
2885
a,a-dicyclopropanoic or dienoic; k, keto-monocyclopropanoic or monoenoic
highest intensity observed are listed.4. Discussion
In the present study, we have directly detected TDM and
TMM from armadillo tissues infected withM. leprae. The pres-
ence of TMM in M. leprae possessing C74-82 a-mycolic acids
has been reported previously [8,18], however, the existence of
keto-mycolate in M. leprae TMM was not clear. We identiﬁed
keto-mycolate clearly in M. leprae TDM and TMM, and the
chain length of keto-mycolate in M. leprae was found to be
shorter than those from slow-growing culturable mycobacteria
such as M. tuberculosis and M. bovis BCG [19].
Previously, no detectable TDM was identiﬁed by the anal-
ysis of the lipids obtained from M. leprae infected armadillo
[9,20]. However, in our hands, we observed a meager but sig-
niﬁcant spot on TLC from M. leprae extract which migrated
to the position of TDM of M. tuberculosis (Aoyama B
strain). When this spot was analyzed by mass spectrometry
in reference to TDM from M. bovis BCG Connaught
(BCG-C), TDM having a–a dimycolates were observed in
the lower mass ranges than m/z 2673 as seen in TDM from
BCG-C (Fig. 2C). Therefore, both M. leprae and M. bovisprae (Thai 53) and M. bovis BCG (Connaught)
M. bovis BCG (Connaught)
80:k76
80:k78, a82:k76
80:k80, a82:k78 a76:k84, a78:k82
81:k81, a82:k80 a76:k86, a78:k84, a80:k82
a76:k87, a78:k85
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k82:k82
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mycolic acid. Molecular ions of TDM with intensities P 30% of the
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Fig. 3. MALDI-TOF mass spectra of M. leprae PGL-I and the deduced chemical structure. (A) The mass spectra of the major cluster ions ranging
from around m/z 1997 (C30:C30) to 2103 (C34:C34) due to PGL-I separated by solvent fractionation, followed by TLC. C30–C34 shows carbon
numbers of two sets of mycocerosate in PGL-I. (B) The chemical structure of M. leprae PGL-I. R indicates mycocerosate.
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to C82 centering at C78), however, the subclass composition
of keto-mycolate diﬀered. M. bovis BCG-C synthesizes multi
sub-classes of ketomycolic acids such as cis-monoenoic, cis-
monocyclopropanoic, cis-monoenoic cis-monocyclopropa-
noic, trans-monoenoic and trans-monocyclopropanoic myco-
lates [21], while M. leprae synthesize only cis-monoenoic
ketomycolate centering at C81 or C83 (Tables 1 and 2)
[22]. Recently, the immunological role of mycolic acid has be-
come a point of focus. The trans-, but not cis-cyclopropana-
tion of mycolic acids in TDM induce massive inﬂammation
in the lesion infected with M. tuberculosis and, in this re-
spects, the trans-cyclopropane structure may be contributing
to virulence [23,24]. Furthermore, recently, it was reported
that the DkasB (a b-keto acyl-ACP synthase gene) mutant
strain of M. tuberculosis synthesized shorter chain mycolate
than the wild ones, and resulted in the loss of keto-mycolic
acid trans-cyclopropanation. The kasB deletion induced the
ability of the mutant strain to persist in infected mice for
up to 600 days without causing disease [25]. Thus, the lack
of trans-cyclopropanoic keto-mycolic acid in M. leprae maycontribute to the low virulency in contrary to substantial
quantities found in most of the slow growing pathogenic
mycobacteria.
In the search for TDM, we also identiﬁed a major cluster
ions in M2 fraction. Detailed analyses showed that the ions
were derived from phenolic glycolipid (PGL-I), which is a ma-
jor species speciﬁc glycolipid of M. leprae. Previously, com-
bined GLC-mass spectroscopic analysis of the trisaccharide
of PGL-I had been achieved, but TOF-mass spectrometric
data have not been reported [26]. We analyzed the M1 fraction
by MALDI TOF mass spectrometry and detected some clus-
ters. Mass spectra of major clusters look like monoglycosyl
phthiocerol diester and diglycosyl phthiocerol diester (data
not shown), which diﬀer from PGL-I in lacking the terminal
sugars [27]. The co-existence of both PGL-I and TDM in
armadillo tissue nodules infected with M. leprae indicates that
these lipids were originated actually fromM. leprae. Thus, this
paper identiﬁes TDM structure of M. leprae for the ﬁrst time
and shows that M. leprae TDM contains only a-mycolic acids
and shorter chain cis-monoenoic keto-mycolic acids, exclu-
sively.
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